cerebral ischemia and infarction.pptx

vinaynandimalla 1,692 views 68 slides Feb 21, 2023
Slide 1
Slide 1 of 68
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68

About This Presentation

pathophysiology of cerebral ischemia and infarction


Slide Content

Cerebral ischemia and infarction Dr . N. Vinay Kumar DM Neurology resident

CEREBRAL ISCHEMIA It is potentially reversible altered state of brain physiology and biochemistry that occurs when substrate delivery is cut off or substantially reduced by vascular stenosis or occlusion. Stroke is defined as an acute neurologic dysfunction of vascular origin with sudden (within sec) or atleast rapid occurrence of symptoms and signs corresponding to involvement of focal areas in the brain.

Pathological alterations in cerebral vessel function Platelets and PMN release vasoactive amines include ADP,TXA2 and serotonin reduce or inhibit NO Vasoconstriction. Atherosclerosis excess production of ROS decrease NO bioavailabilty impaired endothelial dep relaxation. Statins are pleotropic improve vascular function by increase in NOS and reduced NADPH oxidase and Rho kinase. Chronic hypertension oxidative stress and elevated ROS inactivation of NO and endothelial dysfunction

6.Impaired function of many K+ channels leads in cerebral artery dysfunction and vasoconstriction

6.SAH leads to cerebrovascular depolarisation and results in vasospasm due to impaired endothelial dep relaxation,reduced guanyl cyclase, bilirubin oxidation products and reduced K+ channel function

7)Diabetes – hyperglycemia leads to impaired endothelial vascular dilatation due to activation of EDCF protein C kinase. 8. Hyperhomocystenemia leads to endothelial dysfunction due to increased levels of S adenosine methionine levels.

Cerebral stroke subtypes

Risk factors

Thrombosis Refers to an obstruction of blood flow due to a localised occlusive process within one or more blood vessels. The lumen of the vessel is narrowed or occluded by an alteration in the vessel wall or by superimposed clot formation. The most common type of vascular pathology is atherosclerosis .

Atherosclerosis Fibrous and muscular tissues overgrow in the sub intima. Fatty materials form plaques that can encroach on the lumen. Platelets adhere to plaque and form clumps that serve as nidus for the deposition of fibrin, thrombin, and clot. Affects chiefly the larger extracranial and intracranial arteries . The smaller, penetrating arteries are more often damaged by hypertension than by atherosclerotic processes.

Less common vascular pathologies leading to obstruction include Fibromuscular dysplasia Arteritis Dissection of the vessel wall Hemorrhage into plaque At times, the focal vascular abnormality is a functional change in the contractility of blood vessel Intense focal vasoconstriction can lead to decreased blood flow and thrombosis.

Embolism Material formed else where within the vascular system lodges in an artery and blocks blood flow. Blockage can be transient or may persist for hours or days. Most commonly : heart Other sources: 1)major arteries such as aorta, carotid and vertebral arteries. 2)systemic veins.

Decreased systemic perfusion Diminished flow to brain tissue is caused by low systemic perfusion pressure. Most common causes are: 1) Cardiac pump failure : due to Myocardial infarction. 2) Systemic hypotension : due to blood loss or hypovolemia. Lack of perfusion is more generalised than in localised. Poor perfusion is most critical in border zone or called as watershed regions.

Damage caused by ischemia All 3 mechanisms lead to temporary or permanent tissue injury. Permanent injury is termed as infarction . Capillaries or other vessels within the ischemic tissue may also be injured. Reperfusion can lead to leakage of blood into the ischemic tissue resulting in hemorrhagic infarction . Extent of brain damage depends on Location and duration of the poor perfusion. Ability of collateral vessels to reperfuse the tissues at risk.

The systemic blood pressure, blood volume, and blood viscosity also affect blood flow to the ischemic areas. In acute phase : Brain and vascular injuries may lead to brain edema during the hours and days after stroke. In chronic phase : Macrophages gradually ingest the necrotic tissue debris within the infarct leading to shrinkage of infarct and forms gliotic scars.

Cerebral microvessel response to focal ischemia Loss of barrier leading to endothelial cell permeability with subsequent edema Loss of basal lamina and extracellular matrix with haemorrhagic transformation Alteration in cell matrix adhesion Loss of microvessel patency Generation endothelial and leucocyte adhesion molecules

Capilllary permeabilty barrier function is lost in 30 min after ischemia swelling of endothelial and astrocytes with cytoplasm reorganization Capillary expands and rupture Accumulation of fluid in extravascular space Swelling leads to focal no flow phenomena Bradykinin,vegf,MMP,thrombin and protease leads to loss of BBBand microvas ECM Decrease in laminin and fibronectin leads to leakage of blood Beta integrin, p selectin and E selectin are involved in ECM disturbed due to cytokines by glial cells

Proteolysis of microvascular matrix Loss of basal lamina Increase in pro MMP 2, urokinase and plasminogen activator inhibitor Leads to matix and parenchymal degeneration Microvessel cell adhesion- after injury beta integrins and dystroglycan on endothelial cell reduces the adhesion. Focal no flow phenomenon and secondary injury -transient occlusion of brain supplying artery significantly reduces patency of distal microvascular bed . Could be external or internal compression

Initiation of cellular inflammation Ischemia secondary injury to vessels inflammation obstruction by WBC and platelet adhesion Leucocyte diapedesis . Leucocytes interact with endothelial cells expressing P selectins through P-selectin glycoprotein 1 (PSGL-1), leading to their“rolling ” on the endothelial surface. Interaction of leucocyte integrins CD11a/CD18 and CD11b/CD18 with intercellular adhesion molecule 1 (ICAM-1) leads to firm adherence and aggregation of leucocytes. Diapedesis of leucocytes is facilitated by platelet-endothelial cell adhesion molecule 1 (PECAM-1).

Fibrin formation and deposition Fibrinogen exposed to tissue factor leads to formation of fibrin Activated platelets +fibrin Vascular obstruction in capillaries and venules Hemostasis Occurs by expression of activators and inhibitors of thrombosis in vessel walls or by cross talk between vascular cell components TF is the activator of coagulation and breach in endothelium leads to contact of TF and coagulation.

Physiology and pathophysiology of brain ischemia Normal Metabolism and Blood Flow : Brain uses glucose as its sole substrate for energy metabolism. Glucose metabolism leads to conversion of ADP to ATP. A constant supply of ATP is needed to maintain neuronal integrity and to keep the major extracellular Ca++ and Na+ outside the cells and the intracellular K+ within the cells. Production of ATP is much more efficient in the presence of oxygen .

In absence of oxygen anaerobic glycolysis leads to formation of ATP and lactate, the energy yield is relatively small, and lactic acid accumulates within and outside the cells. Brain requires 75 to 100 mg of glucose each minute. Normal CBF = 50-55ml/100g/minute . Cerebral oxygen consumption, is normally 3.5ml/100g/minute . By increasing oxygen extraction from the blood stream, compensation can be made to maintain until CBF is reduced to a level of 20 to 25ml/100g/minute.

Brain energy use and blood flow depend on the degree of neuronal activity. In response to ischemia , the cerebral autoregulatory mechanisms compensate for a reduction in CBF.

Autoregulation The capacity of the cerebral circulation to maintain relatively constant levels of CBF despite changing blood pressure.(80-150mmHg) The range of autoregulation is shifted to the right , i.e. to higher values, in patients with hypertension and to left during hypercarbia .

Maintenance of cerebral blood flow by autoregulation typically occurs within a mean arterial pressure range of 60-150mmHg

Autoregulatory mechanisms The myogenic theory of autoregulation: changes in vessel diameter caused by the direct effect of blood pressure variations on the myogenic tone of the vessel walls. By local vasodilatation Opening the collaterals. Increasing the extraction of oxygen and glucose from the blood.

Cerebral autoregulation during stroke

Between CBF Values of 22ml/100mg/min to 8mL/100mg/ min,brain tissue maintains its structural integrity and can be salvaged with reperfusion.

Development of permanent neurologic sequelae is a time dependent process ; for any given blood flow level, low CBF values are tolerated only for short period

Core of the infarct : Center of the zone where the blood flow is lowest Neurons undergoes necrosis. CBF ranges from 0 to 10ml/100g/min . Ischemic penumbra: Zone of reduced perfusion in the periphery. CBF ranges from 10 to 20ml/100g/min . Electrical failure but not permanent damage. Restoration of blood results in survival. If blood flow is not restored cells undergo death by apoptosis.

Area of oligemia- represents mildly hypoperfused tissue from the normal range down to around 22ml/100mg/min . Usually not at risk of infarction. In hypotension, fever, or acidosis, oligemic tissue can be incorporated into penumbra and subsequently undergo infarction.

impaired perfusion >3min decrease in ATP ↓ mitochondria –loss of incoming oxygen ↓ anaerobic glycolysis release of free radicals accumulation of lactic acid inflammation Damage Edema to BBB

Local Brain Effects of Ischemia Survival of the at-risk tissue depends on Intensity and duration of the ischemia. The availability of collateral blood flow. CBF: - approx.=20ml/100g/min-EEG activity is affected. -<20ml/100g/min-cerebral O2 consumption falls. -<10ml/100g/min-membranes and functions are affected -<5ml/100g/min-neurons cannot survive for long. When neurons become ischemic, a number of biochemical changes potentiate and enhance cell death.

These biochemical effects are: K+ moves out the cell and Ca2+ moves into the cell leads to failure of membrane function and mitochondrial failure . Decreased oxygen availability leads to formation of oxygen free radicals. These free radicals cause peroxidation of fatty acids in cell organelles and plasma membranes, causing severe cell dysfunction. Anerobic glycolysis leads to an accumulation of lactic acid and decrease in pH. The resulting acidosis also greatly impairs cell metabolic functions .

Excitatory neurotransmitters (glutamate, aspartate ) is significantly increased in regions of brain ischemia. Hypoxia , hypoglycemia and ischemia all contribute to cause energy depletion and an increase in glutamate release but a decrease in glutamate uptake. Glutamate entry opens membranes and increases Na+ and Ca2+ influx into cells . Large influxes of Na are followed by entry of chloride ions and water, causing cell swelling and oedema. Glutamate is an agonist at both NMDA and non NMDA receptors types, but only NMDA receptors are linked to membrane channel with high calcium permeability.

All these metabolic changes cause a self perpetuating cycle leading to more local biochemical changes, which in turn cause more neuronal damage. At some point, the process of ischemia becomes irreversible, despite of reperfusion. At times, although the severity of ischemia is insufficient to cause neuronal necrosis, ischemia may cause programmed cell death referred to as apoptosis.

Effects at cellular level

Excitotoxicity Pathological process by which neurons are damaged by the overstimulation of receptors by the excitatory neurotransmitter glutamate, such as the NMDA receptor and AMPA receptor.

Fig. 1. The dual role of NMDA receptors in determining the fate of neurons : binding of glutamate to extrasynaptic NMDARs dephosphorylates cAMPresponsive element-binding protein (CREB), inactivates the extracellular signal-regulated kinase (ERK) pathway and promotes cell death, while binding of glutamate to synaptic NMDARs promotes cell survival through activation of the phosphoinositide-3-kinase (PI3K)/Akt pathway, which inactivates glycogen synthase kinase 3 β ( GSK3 β ), the pro-apoptotic Bcl-2 associated death promotor (BAD), pro-apoptotic p53, and c-Jun N-terminal kinase (JNK)/p38 activator apoptosis signal-regulating kinase 1 (ASK1)

In the ischemic zone, the glutamate binds to postsynaptic receptors which triggers increased calcium influx through glutamate receptor-coupled ion channels. Glutamate overstimulates NMDA, AMPA, Kainite type glutamate receptors. Results in sodium influx and potassium efflux through the glutamate receptor activated membrane channels. NMDA channels are highly permeable to calcium and contribute to influx of calcium from extracellular space and results in cell death after ischemic stroke.

increased calcium levels in cytosol ↓ Increased activation of calcium dependent synthases and proteases ↓ Degradation of cytoskeletal and enzymatic proteins Increased levels of NO and peroxynitrite within the cell through activation of degrading enzymes such as phospholipase, proteases and endonucleases.

Potassium efflux through NMDA channels can increase caspase activity, triggering apoptosis. Primary caspases responsible for apoptosis due to ischemic stroke are caspases 9 and 3. Caspase 9 activates caspase 3. Caspase 3 degrade substrate proteins within the cell and produce internucleosomal endonuclease activity and DNA fragmentation.

Oxidative stress A potential pathway for cellular damage in ischemic stroke may be the occurrence of oxidative stress, which is the increased occurrence of ROS above physiological levels. Free radicals can cause membrane damage through peroxidation of unsaturated fattyacids in the phospholipids making up the cell membrane.

Apoptosis Programmed cell death. Which involves: Shrinkage of the cell cytoplasm Cleavage of DNA within the nucleus Condensation of chromatin in the nucleus Formation of apoptotic bodies Cell death

Mitochondria mediated Translocation of pro-apoptotic Bcl-2 members like Bax into the mitochondria, a cascade of events are triggered. This leads to mitochondria releasing substances such as cytochrome c ,procaspase 9 from its intermembrane space.

Main pathways are leading to apoptosis . Opening of the mitochondrial permeability transition pore (MPTP) leads to the release of cytochrome C ( cyt C), which together with the cytosolic apoptotic-protease-activating factor-1 (Apaf-1) activates procaspase-9. Active caspase-9 further activates caspases-3 and 7, leading to the execution phase of caspase-dependent apoptosis. The mitochondria also release apoptosis-inducing factor (AIF), high- temperaturerequirement protein A (HtrA2/OMI), as well as a second mitochondrion-derived activator of caspase/direct inhibitor of apoptosis-binding protein with low pI (SMAC/DIABLO), which inhibits the antiapoptotic X chromosome-linked inhibitor-of-apoptosis protein (XIAP), thereby leading to apoptosis The binding of Fas ligands ( FasL ) to Fas receptors recruits the cytoplasmic Fas -associated death domain (FADD) and pro-caspase-8, forming together the death-inducing signaling complex (DISC), which leads to activation of pro-caspase-8 and triggering of the extrinsic pathway of apoptosis.

Endoplasmic reticulum ER initiates unfolded protein response(UPR). Three ER transmembrane effector proteins are activated(PERK,IRE1,and ATF-6). IRE1 has been shown to be involved in the activation of caspase-12.

Cerebral edema and increased intracranial pressure There are 2 types of cerebral edema : 1)Cytotoxic edema 2)Vasogenic edema leads to shifts in position of brain tissue and herniation of brain contents from one compartment to another.

Cytotoxic edema : Water accumulation inside cells. Caused by energy failure , with movement of ions and water across the cell membranes into cells. Brain swelling caused by cytotoxic edema means a large volume of dead or dying brain cells , which implies bad outcome. Usually seen after arterial occlusion due to energy failure.

Vasogenic edema Fluid within the extracellular space . Influenced by hydrostatic pressure factors and by osmotic factors. Breakdown of BBB→proteins and other macromolecules enter the Extracellular space→exert osmotic gradient→pulling water into the extracellular space. Preferentially involves cerebral white matter.

Ischemic cascade Lack of oxygen supply to ischemic neurones ATP depletion Membrane ions system stops functioning Depolarisation of neuron Influx of calcium Release of neurotransmitters, including glutamate, activation of N-metyl -D- aspartate and other excitatory receptors at the membrane of neurones Further depolarisation of cells Further calcium influx

Thank you

References J P Mohr Stroke patho physiology, diagnosis and management 5 th edition. Jurcau A, Ardelean IA. Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke. J Integr Neurosci . 2021 Sep 30;20(3):727-744. doi : 10.31083/j.jin2003078. PMID: 34645107. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020 Oct 15;21(20):7609. doi : 10.3390/ijms21207609. PMID: 33076218; PMCID: PMC7589849. Qin, C., Yang, S., Chu, YH.  et al.   Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions.  Sig Transduct Target Ther   7 , 215 (2022). Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci . 2003 May;4(5):399-415. doi : 10.1038/nrn1106. PMID: 12728267.
Tags